San Diego-based startup Debut Biotech has teamed up with Korean firm GeneChem to develop a series of human milk oligosaccharides (HMOs) – health-promoting carbohydrates found in human breastmilk – that have never been commercialized before, using a novel ‘cell-free’ biomanufacturing process.
July 8, 2022
This clipping was added via the Protein Report NewsEngine, a market intelligence tool for tracking developments in the protein industries. Learn more.
